Subscribe
THEMIS trial results showed a statistically significant reduction in risk of MACE with ticagrelor plus aspirin vs aspirin alone in patients with CAD at high risk of first heart attack or stroke.
Asthma Linked with Incident CVD in Framingham Offspring Cohort Analysis
REDUCE-IT: Icosapent Ethyl Shows Significant Reduction in Coronary Revascularizations
Antihypertensive Drugs Found Safe for Patients with COVID-19 in New Study
FDA Approves Dapagliflozin to treat HFrEF
Girish Kunapareddy, MD; Sara M. Tolaney, MD, MPH
June 15, 2026
Marla D. Lipsyc-Sharf, MD; Richard Zelkowitz, MD
June 17-19, 2026
Seth A. Wander, MD, PhD; Kate Baxstrom, MD
Richard Bedlack, MD, PhD
June 23, 2026
1 Session is Available!
Terry Heiman-Patterson, MD
Gerald Bernard Appel, MD; Ellie Kelepouris, MD, FACP, FAHA
Selina R. McGee, OD, FAAO
Arjan Hura, MD; Neda Shamie, MD; Kristin Barnes, OD
John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA; John Hovanesian, MD, FACS
Seth A. Wander, MD, PhD; Yang Liu, MD
Yelda Nouri, MD; Sara Nunnery, MD, MSCI
July 10-11, 2026
Rachel N. Grisham, MD; Ramez N. Eskander, MD; Oladapo Yeku, MD, PhD